Anyanwu Nneoma C J, Premadasa Lakmini S, Naushad Wasifa, Okeoma Bryson C, Mahesh Mohan, Okeoma Chioma M
bioRxiv. 2025 Jan 9:2025.01.09.632234. doi: 10.1101/2025.01.09.632234.
Extracellular particles (EPs) are produced/secreted by cells from all domains of life and are present in all body fluids, brain, and gut. EPs consist of extracellular vesicles (EVs) made up of exosomes, microvesicles, and other membranous vesicles; and extracellular condensates (ECs) that are non-membranous carriers of lipid-protein-nucleic acid aggregates. The purity of EVs|ECs, which ultimately depends on the isolation method used to obtain them is critical, particularly EVs|ECs from the gastrointestinal (GI) tract that is colonized by a huge number of enteric bacteria. Therefore, identifying GI derived EVs|ECs of bacterial and host origin may serve as a window into the pathogenesis of diseases and as a potential therapeutic target.
Here, we describe the use of high-resolution particle purification liquid chromatography (PPLC) gradient-bead-column integrated with polyvinylpolypyrrolidone (PVPP)-mediated extraction of impurities to isolate GI-derived EPs.
PVPP facilitates isolation of pure and functionally active, non-toxic EVs ColEVs from colonic contents. ColEVs are internalized by cells and they activate HIV LTR promoter. In the absence of PVPP, ColEVs have a direct reductive potential of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) absorbance in a cell-free system. Assessment of the origin of ColEVs reveals that they are composed of both bacteria and host particles. This protocol requires ∼12 hours (5 hours preprocessing, 7 hours isolation) to complete and should be used to purify EVs from sources contaminated with microbial agents to improve rigor. Additionally, this protocol provides a robust tool for researchers and clinicians investigating GI-derived EVs and the translational use of GI-derived EVs for diagnostic and therapeutic use.
ColEVs but not ColECs are present in colonic content (GI tract) and can be isolated with gradient or single bead PPLC column.ColEVs isolated without PVPP are toxic to cells and they have a direct reductive potential of MTT. Addition of PVPP treatment in the isolation protocol results in clean and non-toxic ColEVs that transactivate the HIV LTR promoter.
细胞外颗粒(EPs)由来自生命各领域的细胞产生/分泌,存在于所有体液、大脑和肠道中。EPs 由细胞外囊泡(EVs)组成,EVs 又由外泌体、微囊泡和其他膜性囊泡构成;还包括细胞外凝聚物(ECs),它们是脂质 - 蛋白质 - 核酸聚集体的非膜性载体。EVs|ECs 的纯度至关重要,其最终取决于用于获取它们的分离方法,尤其是来自被大量肠道细菌定殖的胃肠道(GI)的 EVs|ECs。因此,鉴定源自胃肠道的细菌和宿主来源的 EVs|ECs 可能成为洞察疾病发病机制的窗口以及潜在的治疗靶点。
在此,我们描述了使用高分辨率颗粒纯化液相色谱(PPLC)梯度 - 珠柱结合聚乙烯聚吡咯烷酮(PVPP)介导的杂质提取来分离源自胃肠道的 EPs。
PVPP 有助于从结肠内容物中分离出纯净、功能活跃且无毒的 EVs(结肠 EVs,ColEVs)。ColEVs 可被细胞内化并激活 HIV LTR 启动子。在没有 PVPP 的情况下,ColEVs 在无细胞系统中对 MTT(3 -(4,5 - 二甲基噻唑 - 2 - 基)- 2,5 - 二苯基四氮唑溴盐)吸光度具有直接还原电位。对 ColEVs 来源的评估表明它们由细菌和宿主颗粒组成。该方案需要约 12 小时(5 小时预处理,7 小时分离)完成,应被用于从受微生物污染的来源中纯化 EVs,以提高严谨性。此外,该方案为研究人员和临床医生研究源自胃肠道的 EVs 以及将源自胃肠道的 EVs 用于诊断和治疗用途的转化应用提供了一个强大的工具。
结肠内容物(胃肠道)中存在 ColEVs 而非 ColECs,可通过梯度或单珠 PPLC 柱分离。未使用 PVPP 分离的 ColEVs 对细胞有毒,且对 MTT 具有直接还原电位。在分离方案中添加 PVPP 处理可得到能激活 HIV LTR 启动子的纯净无毒的 ColEVs。